Kascaid
Immune Monitoring Biosensor Platform
San Francisco, United States · Founded 2024 · $2.3M raised
- Headquarters
- San Francisco, California
- Founded
- 2024
- Business Model
- B2B
- Website
- kascaid.bio
- Total Funding
- $2.3M
- Last Round
- $2.3M Pre-SeedJul 2025
- Rounds
- 1
About
Develops interstitial fluid biosensors for real-time immune monitoring and molecular diagnostics at the point of care.
Summary
Kascaid is a Biotech company based in San Francisco, United States, founded in 2024. It has raised $2.3M in total across 1 round, most recently a $2.3M Pre-Seed round in Jul 2025. Investors include Boost VC, 2048 Ventures and Spacecadet Ventures.
Tech & App Stack
3 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Jul 2025
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company